Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: DZIĘGIELEWSKI
Liczba odnalezionych rekordów: 1



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku

1/1

Tytuł oryginału: Intercalation of imidazoacridinones to DNA and its relevance to cytotoxic and antitumor activity.
Autorzy: Dzięgielewski Jarosław, Ślusarski Bartłomiej, Konitz Antoni, Składanowski Andrzej, Konopa Jerzy
Źródło: Biochem. Pharmacol. 2002: 63 (9) s.1653-1662, il., tab., bibliogr. 33 poz.
Sygnatura GBL: 304,395

Hasła klasyfikacyjne GBL:
  • farmacja
  • onkologia

    Typ dokumentu:
  • praca doświadczalna
  • praca opublikowana za granicą
  • tytuł obcojęzyczny

    Streszczenie angielskie: Imidazoacridinones (IA) are a class of antitumor agents which includes C-1311, an interesting drug in clinical trials. This study investigated the mechanism of IA binding to DNA for a series of 13 analogs that differ in their cytotoxic potency. Using C-1311 as a model compound, crystallographic, spectroscopic and biochemical techniques were employed to characterize drug-DNA interactions. X-ray crystallographic analysis revealed a planar structure of imidazoacridinone core that is capable of intercalative DNA bibding. Accordingly, C-1311 binding to DNA followede "classical" pattern observed for intercalation, as proved by tha DNA topoisomerase I - unwinding experiments, with relatively weak binding affinity (Ki = 1.2 x 10**5 M-1), and the binding site size of 2.4 bp. Other IA also bound to DNA with the binding affinity in the range of 10**5 M-1 and binding site size of 2-3 bp, suggesting a prevalence of the intercalative mechanism, similar to C-1311. Considerable DNA binding affinity was displayed by all highly cytotoxic derivatives. However, none of the analyzed drug-DNA binding parameters was significantly correlated with IA biological activities such as cell growth. DNA and RNA synthesis inhibition, or tumor growth inhibition, which suggests that the IA ability to non-covalently bind to DNA is not crucial for their biological activity. These results show that the ability to intercalate into DNA is a prominent attribute of IA, although factors other intercalative binding seem to be required for the biological activities of IA drugs.

    stosując format: